Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E David

Showing results (1091-1100 of 1,174) with videos related to

Pageof 118
Sort By:
The Journal of Infectious Diseases|September 3, 2022
Irrigation-Induced Environmental Changes Sustain Malaria Transmission and Compromise Intervention EffectivenessGuofa Zhou, Elizabeth Hemming-Schroeder, Brook Jeang, et al.
Journal of Medicinal Chemistry|July 31, 1998
Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 7. 8-Arylethyldipyridodiazepinones as potent broad-spectrum inhibitors of wild-type and mutant enzymesJ M Klunder, M Hoermann, C L Cywin, et al.
Clinical Pharmacology and Therapeutics|February 24, 2018
Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a DiseaseRobert N Schuck, Janet Woodcock, Issam Zineh, et al.
The Canadian Journal of Urology|October 13, 2020
Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IVE David Crawford, Gerald Andriole, Stephen J Freedland, et al.
Journal of the National Cancer Institute|April 20, 2006
Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16Daniel P Petrylak, Donna Pauler Ankerst, Caroline S Jiang, et al.
Journal of the National Cancer Institute|March 17, 2005
Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trialGerald L Andriole, David L Levin, E David Crawford, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2011
Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter studyL S Azevedo, E P Lasmar, F L C Contieri, et al.
Neuron|May 30, 2009
Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depressionDenis J David, Benjamin Adam Samuels, Quentin Rainer, et al.
Journal of the National Cancer Institute|April 2, 2010
Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilitiesAdeyinka O Laiyemo, Chyke Doubeni, Paul F Pinsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2018
Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921Maha Hussain, Catherine M Tangen, Ian M Thompson, et al.
Pageof 118

Showing results (1091-1100 of 1,174) with videos related to

Sort By:
Pageof 118
The Journal of Infectious Diseases|September 3, 2022
Irrigation-Induced Environmental Changes Sustain Malaria Transmission and Compromise Intervention EffectivenessGuofa Zhou, Elizabeth Hemming-Schroeder, Brook Jeang, et al.
Journal of Medicinal Chemistry|July 31, 1998
Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 7. 8-Arylethyldipyridodiazepinones as potent broad-spectrum inhibitors of wild-type and mutant enzymesJ M Klunder, M Hoermann, C L Cywin, et al.
Clinical Pharmacology and Therapeutics|February 24, 2018
Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a DiseaseRobert N Schuck, Janet Woodcock, Issam Zineh, et al.
The Canadian Journal of Urology|October 13, 2020
Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IVE David Crawford, Gerald Andriole, Stephen J Freedland, et al.
Journal of the National Cancer Institute|April 20, 2006
Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16Daniel P Petrylak, Donna Pauler Ankerst, Caroline S Jiang, et al.
Journal of the National Cancer Institute|March 17, 2005
Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trialGerald L Andriole, David L Levin, E David Crawford, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2011
Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter studyL S Azevedo, E P Lasmar, F L C Contieri, et al.
Neuron|May 30, 2009
Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depressionDenis J David, Benjamin Adam Samuels, Quentin Rainer, et al.
Journal of the National Cancer Institute|April 2, 2010
Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilitiesAdeyinka O Laiyemo, Chyke Doubeni, Paul F Pinsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2018
Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921Maha Hussain, Catherine M Tangen, Ian M Thompson, et al.
Pageof 118